Patients take 50% on average of their required medication

We know that the average patient takes 50% worth of their medication'*. It is our aim to help empower patients to increase their medication taking and to decrease escalting health costs on society in general.  

We aim at providing drug delivery devices that help patients take a "shortcut to better health." We believe that by providing electronic reminders and dose counting solutions, we can help keep patients on the fast track to better health.

Intelligent Compliance Solutions

We know that patients are essentially human beings, and as human beings they need a helping hand to remember their medication. B&O Medicom has thought about the human element when designing what we like to call intelligent patient compliance device solutions.

Applying our technological expertise with insight a passion for user friendly and intuitive design has resulted in our range of compliance device solutions:

The Helping Hand Range
One approach of Medicom is to provide patients with an electronic device that works with blister packs for tablets and capsules, these devices help patients to remember and track their prescribed medication. This device has a multicoloured diode display that serves both as a reminder and a compliance indicator. See also clinical trial application and advanced bluetooth application

Inhalation Range
We offer fully customisable inhalers designed with a focus on ease of use and which offer extra optional compliance features such as a compliance cap that reminds the user to take his/her (preventive) medication correctly through a visual signal.

Injection Range
We have been working on the design, development and production of injection pens for over 15 years. We both offer injections systems and pen accessories.

Diagnostic Solutions
We have over 15 years experience in developing unique sensor technology for medical and non-medical applications. The sensor technology forms the basis of electronic stethoscopes used by physicians today.

* WHO Report (2003), “ Adherence to Long-Term Therapies, Evidence for Action”